Trials / Unknown
UnknownNCT04161287
Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE
Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Hepatocellular Carcinoma ≤5 cm With or Without Transcatheter Arterial Chemoembolization (TACE)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 330 (estimated)
- Sponsor
- Beijing 302 Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to compare efficacy and adverse reactions of hepatocellular carcinoma participants (≤5cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.
Conditions
- Small Hepatocellular Carcinoma
- Stereotactic Body Radiation Therapy
- Transcatheter Arterial Chemoembolization
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transcatheter arterial chemoembolization | The hepatocellular carcinoma patients (≤5cm）who received SBRT are devided into two groups: with TACE and SBRT alone. |
Timeline
- Start date
- 2019-10-11
- Primary completion
- 2023-12-11
- Completion
- 2025-01-11
- First posted
- 2019-11-13
- Last updated
- 2024-02-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04161287. Inclusion in this directory is not an endorsement.